The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF) - practical implications

por Wells, Athol U
Publicado 2013

“Any fool can make a rule and any fool will mind it”

por Wells, Athol U.
Publicado 2016

Analyses of the Efficacy and Safety of Antifibrotic Therapies in Non-IPF Pulmonary Fibrosis, Progressing Despite Management

por Wells, Athol U.
Publicado 2022

Residual Lung Disease at 6-month Follow-up CT after COVID-19: Clinical Significance Is a Key Issue

por Wells, Athol U, Devaraj, Anand
Publicado 2021

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults

por Scholand, Mary Beth, Wells, Athol U.
Publicado 2022

Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response

por Cottin, Vincent, Cordier, Jean-François, Wells, Athol U
Publicado 2011

“ILD” after COVID‐19 Infection: A Catalogue of Uncertainties

por Wells, Athol U., Devaraj, Anand, Desai, Sujal R.
Publicado 2021

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

por George, Peter M, Wells, Athol U, Jenkins, R Gisli
Publicado 2020

Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”

por Brown, Kevin K., Schlenker-Herceg, Rozsa, Wells, Athol U.
Publicado 2020

The role of precision medicine in interstitial lung disease

por Maher, Toby M., Nambiar, Anoop M., Wells, Athol U.
Publicado 2022

Comorbidities in interstitial lung diseases

por Margaritopoulos, George A., Antoniou, Katerina M., Wells, Athol U.
Publicado 2017

Personalised medicine in interstitial lung diseases: Number 6 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche

por Kokosi, Maria A., Margaritopoulos, George A., Wells, Athol U.
Publicado 2018

COVID‐19 related lung pathology: old patterns in new clothing?

por Nicholson, Andrew G, Osborn, Michael, Devaraj, Anand, Wells, Athol U
Publicado 2020

Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?

por Cottin, Vincent, Brown, Kevin K., Flaherty, Kevin R., Wells, Athol U.
Publicado 2022

Pulmonary fibrosis associated with psychotropic drug therapy: a case report

por Thornton, Clare, Maher, Toby M, Hansell, David, Nicholson, Andrew G, Wells, Athol U
Publicado 2009

Pulmonary capillary haemangiomatosis – An unusual cause of hypoxia

por Aston, Kerry, Riddell, Gareth J., Sheppard, Mary N., Wells, Athol U., Riley, Marshall S.
Publicado 2012

Smoking and interstitial lung diseases

por Margaritopoulos, George A., Vasarmidi, Eirini, Jacob, Joseph, Wells, Athol U., Antoniou, Katerina M.
Publicado 2015

Smoking and Pulmonary Fibrosis: Novel Insights

por Samara, Katerina D., Margaritopoulos, George, Wells, Athol U., Siafakas, Nikolaos M., Antoniou, Katerina M.
Publicado 2011

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges

por Kewalramani, Namrata, Machahua, Carlos, Poletti, Venerino, Cadranel, Jacques, Wells, Athol U., Funke-Chambour, Manuela
Publicado 2022

Interstitial pneumonia with autoimmune features: challenges and controversies

por Mackintosh, John A., Wells, Athol U., Cottin, Vincent, Nicholson, Andrew G., Renzoni, Elisabetta A.
Publicado 2021